Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines.
about
Combined effects of Cantide and chemotherapeutic drugs on inhibition of tumor cells' growth in vitro and in vivo.Emerging drugs to treat squamous cell carcinomas of the head and neck.Gene therapy for carcinoma of the breast.Targeting the epidermal growth factor receptorEpidermal growth factor inhibition in solid tumours.Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancer.Molecular biology of epidermal growth factor receptor inhibition for cancer therapy.Bcl-x(L) antisense oligonucleotides radiosensitise colon cancer cells.Breast cancer subtypes: response to radiotherapy and potential radiosensitisation.Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignanciesEGFR(s) in aging and carcinogenesis of the gastrointestinal tract.Targeting the EGF receptor ectodomain in the context of cancer.Molecular imaging metrics to evaluate response to preclinical therapeutic regimens.Gefitinib (ZD1839) increases the efficacy of cisplatin in ovarian cancer cells.Epidermal growth factor receptor signaling in nonsmall cell lung cancer.The biological effect of 125I seed continuous low dose rate irradiation in CL187 cells.Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5-fluorouracil and docetaxel in head and neck squamous cell carcinoma.Lipid-mediated delivery of oligonucleotide to pulmonary endothelium.
P2860
Q35010232-A8346253-40B7-4185-8A21-CFEE5DBCA6AAQ35098322-237B489F-1643-4DA2-93AC-6B978BF77C7FQ35609061-C671F911-8CAD-43F9-B2EF-98D636DE1803Q35828552-81397EE6-1815-418B-8E25-04D96C158247Q36239648-C19D0806-245A-4FAF-A9EB-307C2D2E6734Q36302860-D9527589-DA4B-4DAC-9CB8-D175CECC6091Q36481002-060A586D-21F9-4F30-A562-44E5D0131704Q36671167-28D14508-FD6A-45C1-8732-BCC00547D629Q36715983-A22F0D19-0C81-4F98-90C9-2926C0A027F7Q36812355-A0D64FA1-94A9-42F3-9D22-BDB232E66B42Q37552436-D06E563D-5A09-40C6-BBA2-5F19C1638E05Q37600910-F5A94D71-FDDB-4C4B-A3DB-B30E37BD1C5BQ37825149-B1E2B590-CD7D-445F-BC3E-30949F8939BBQ39400141-34F8F98F-F73A-47CE-AD8B-AD3C955B7AF2Q39752055-68A4600A-FE99-40C1-A567-B98400819C62Q39890007-2DD1B390-11E2-48FA-A0D8-4C7D235C0E07Q40230093-3304613E-C3C6-47D6-B49D-77DC47669BE1Q54540731-B68EC9A5-0214-4305-9533-8576AECD8A24
P2860
Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Antisense oligonucleotides tar ...... gs in human cancer cell lines.
@en
Antisense oligonucleotides tar ...... gs in human cancer cell lines.
@nl
type
label
Antisense oligonucleotides tar ...... gs in human cancer cell lines.
@en
Antisense oligonucleotides tar ...... gs in human cancer cell lines.
@nl
prefLabel
Antisense oligonucleotides tar ...... gs in human cancer cell lines.
@en
Antisense oligonucleotides tar ...... gs in human cancer cell lines.
@nl
P2093
P2860
P50
P356
P1476
Antisense oligonucleotides tar ...... ugs in human cancer cell lines
@en
P2093
A R Bianco
E R Kandimalla
G Borriello
J Mendelsohn
P2860
P304
P356
10.1002/IJC.1335
P577
2001-07-01T00:00:00Z